drugset / Trial / NCT00174395

A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine

NCT00174395

Phase 4 Completed 220 enrolled Viatris Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

To evaluate the efficacy of early intervention (dosing within 2 hours of onset of the migraine attack) with eletriptan 40mg on mild versus moderate to severe pain intensity of migraine.

Timeline

Start
2005-03
Primary completion
Completion
2006-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Eletriptan Small molecule 40 mg

Indications